Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 March 2021 | Story Giselle Baillie | Photo Supplied
Residence members who led the project, included: Bohlokwa Rantja, the Residence Prime, and Transformation Committee members Nsuku Mutemela, Ofentse Motlakeng, Phindile Tjale, Madinku Mabala, Mmapopi Motshoso, Karabo Shuping, and Tagane Sekete.

The University of the Free State (UFS) Council approved and adopted Lehakwe House as the new name for the NJ van der Merwe residence on the Bloemfontein Campus. The approval on 26 November 2020 followed a lengthy process of deliberation, consultation, and public engagement that has taken place since November 2019 and is aligned with the UFS Policy on Naming and Renaming. The name-change process was initiated by the Prime and Transformation Committee of the residence, guided by the Unit for Institutional Change and Social Justice and supported by a multi-stakeholder committee representative of the residence, the Housing and Residence Affairs Office, the Department of Student Affairs, the Student Representative Council, and alumni.

Lehakwe – a precious gem

Following a lengthy evaluation process of the names submitted through a public voting and recommendation platform in July 2020, ‘Lehakwe’ – a Sesotho word referring to a ‘precious gem’ – emerged as the front runner. As many current and past members of the residence attest, this womxn’s residence has come to occupy a significant space within the hearts and minds of UFS students and the UFS community, given that its spirit has always been closely aligned with the constitutional values of dignity, equality, and freedom and with the human values of ubuntu. In this vein, the new name of ‘Lehakwe’ presents a consolidation of constitutional and university values into the day-to-day thinking, learning, living, and legacy spaces of students, as well as everyone who interacts and engages with the UFS. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept